Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsStem CellsGraft vs Host DiseaseTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem CellsWhole-Body IrradiationBone and BonesTransplantation ConditioningStem Cell TransplantationAnemia, AplasticLeukemiaTransplantation ChimeraLiver TransplantationGraft SurvivalTissue DonorsBusulfanBone Marrow PurgingMice, Inbred C57BLHistocompatibility TestingHistocompatibilityHematopoiesisCyclophosphamideTransplantation, IsogeneicCell DifferentiationBone Marrow DiseasesKidney TransplantationT-LymphocytesRecurrenceCombined Modality TherapyRadiation ChimeraLeukemia, Myelogenous, Chronic, BCR-ABL PositiveEmbryonic Stem CellsTime FactorsLeukemia, Myeloid, AcuteHematologic NeoplasmsTreatment OutcomeImmunosuppressive AgentsBone Marrow ExaminationRemission InductionGraft RejectionAdult Stem CellsCells, CulturedPrecursor Cell Lymphoblastic Leukemia-LymphomaHepatic Veno-Occlusive DiseaseBone RemodelingTransplantation ImmunologyColony-Forming Units AssayImmunosuppressionLeukemia, MyeloidBone Marrow NeoplasmsLymphocyte DepletionGraft vs Host ReactionFlow CytometryMesenchymal Stem Cell TransplantationMice, Inbred BALB CAcute DiseaseLymphoma, Non-HodgkinChimeraLeukocyte TransfusionHeart TransplantationSevere Combined ImmunodeficiencySpleenHLA AntigensSurvival AnalysisMyelodysplastic SyndromesPluripotent Stem CellsRetrospective StudiesStem Cell NicheHematologic DiseasesCell SeparationCell LineageMesenchymal Stromal CellsMice, KnockoutLung TransplantationLymphocyte TransfusionCyclosporineActuarial AnalysisBone DensityAntineoplastic Combined Chemotherapy ProtocolsAntigens, CD34Granulocyte Colony-Stimulating FactorHematopoietic Stem Cell MobilizationImmune ToleranceLymphocyte ActivationNuclear FamilyCarmustineAntigens, CDLeukocyte CountGraft vs Leukemia EffectOrgan TransplantationGraft vs Tumor EffectPeripheral Blood Stem Cell TransplantationStem Cell FactorPancytopeniaFollow-Up StudiesSurvival Rate